The procoagulant effect of Vitamin-K antagonists in patients with atrial fibrillation, atherosclerosis and deep venous thrombosis

被引:0
|
作者
Al Dieri, R. [1 ]
ten Cate-Hoek, A. J. [2 ]
ten Cate, H. [2 ]
Hemker, H. C. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Cardiovasc Res Inst, Synapse Bv, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP-WE-683
引用
收藏
页码:857 / 857
页数:1
相关论文
共 50 条
  • [41] Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients
    Kooistra, Hilde A. M.
    Piersma-Wichers, Margriet
    Kluin-Nelemans, Hanneke C.
    Veeger, Nic J. G. M.
    Meijer, Karina
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2016, 9 (04): : 388 - +
  • [42] “To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists”
    Francesco Dentali
    Nicola Mumoli
    Monica Gianni
    Marco Cei
    Internal and Emergency Medicine, 2015, 10 : 765 - 767
  • [43] Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR
    Kawashima, Hideyuki
    Watanabe, Yusuke
    Hioki, Hirofumi
    Kozuma, Ken
    Kataoka, Akihisa
    Nakashima, Makoto
    Nagura, Fukuko
    Nara, Yugo
    Yashima, Fumiaki
    Tada, Norio
    Naganuma, Toru
    Yamawaki, Masahiro
    Yamanaka, Futoshi
    Shirai, Shinichi
    Mizutani, Kazuki
    Tabata, Minoru
    Ueno, Hiroshi
    Takagi, Kensuke
    Yamamoto, Masanori
    Hayashida, Kentaro
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (22) : 2587 - 2597
  • [44] Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
    Li, Wenhao
    Zhou, Yanxia
    Chen, Siqi
    Zeng, Dewang
    Zhang, Haidong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [45] EFFICACY OF ANTICOAGULATION WITH VITAMIN K ANTAGONISTS IN ACUT STROKE PATIENTS WITH ATRIAL FIBRILLATION - HUNGARIAN RESULTS
    Sas Attila
    Csontos Krisztina
    Lovasz Rita
    Valikovics Attila
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (1-2): : 47 - 51
  • [46] Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort
    de Sousa, Luis Pereira
    Burba, Ivana
    Ruperto, Cettina
    Lattuada, Luca
    Barbone, Fabio
    Di Chiara, Antonio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (07) : 534 - 540
  • [47] Anticoagulation in Deep Venous Thrombosis: Current Trends in the Era of Non-Vitamin K Antagonists Oral Anticoagulants
    Papakonstantinou, Panteleimon E.
    Tsioufis, Costas
    Konstantinidis, Dimitris
    Iliakis, Panagiotis
    Leontsinis, Ioannis
    Tousoulis, Dimitrios
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (23) : 2692 - 2702
  • [48] Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists
    Emilie Gieling
    Frank de Vries
    Rachael Williams
    Hein A. W. van Onzenoort
    Anthonius de Boer
    Vincent ten Cate
    Cornelis Kramers
    Andrea Burden
    International Journal of Clinical Pharmacy, 2019, 41 : 1536 - 1544
  • [49] Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists
    Gieling, Emilie
    de Vries, Frank
    Williams, Rachael
    van Onzenoort, Hein A. W.
    de Boer, Anthonius
    ten Cate, Vincent
    Kramers, Cornelis
    Burden, Andrea
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (06) : 1536 - 1544
  • [50] EFFECT OF VITAMIN-K ON PIVKA AND ITS ASSOCIATED PROCOAGULANT PROTEINS IN LIVER-DISEASE
    MALIA, RG
    PRESTON, FE
    BLACKBURN, EK
    THROMBOSIS AND HAEMOSTASIS, 1977, 38 (01) : 157 - 157